NARI 240816 40.00C (NARI240816C40000) Stock Options, News & Quotes

US OptionsDetailed Quotes

NARI240816C40000

Watchlist

7.00
-0.52-6.91%

15min DelayClose Aug 5 16:00 ET

7.00High7.00Low

Intraday

5D
Daily

News

The Inari Medical, Inc. (NASDAQ:NARI) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
Yahoo FinanceAug 2 08:23 ET
CCORF Maintains Inari Medical(NARI.US) With Buy Rating, Maintains Target Price $71
Moomoo NewsAug 2 07:35 ET · Ratings
Earnings Update: Inari Medical, Inc. (NASDAQ:NARI) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts
Simply Wall StAug 1 06:39 ET
Inari Medical Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Yahoo FinanceAug 1 06:21 ET
Baird Maintains Inari Medical(NARI.US) With Buy Rating, Cuts Target Price to $63
Moomoo NewsAug 1 03:32 ET · Ratings
Express News | Inari Medical Shares Are Trading Lower After the Company Reported Q2 Financial Results and Issued FY24 Revenue Guidance Below Estimates. Also, Truist Securities and Baird Lowered Their Respective Price Targets on the Stock
BenzingaJul 31 12:02 ET

Comments

10baggerbamm

Jul 30 15:49

$Inari Medical(NARI.US)$ just another Russell 2000 stock blowing up but don't worry about buying these small caps people..

Moomoo AI

Jan 9 05:37

CEO Drew Hykes attributes Q4's robust revenue growth to healthy VTE procedure volumes, emerging therapies' traction, and strong international performance. He also highlights progress across all RCTs and the U.S. launch of LimFlow, emphasizing commitment to strong growth and operating profitability.

Press Release: Inari Medical Announces Preliminary 2023 Revenue and 2024 Guidance

Moomoo AI

Jan 8 08:11

The appointment of Rhonda Robb, with her extensive experience and proven track record, is expected to lead Okami Medical into its next phase of expansion and growth, particularly as the company prepares to commercialize its LOBO Vascular Occlusion System.

Press Release: OKAMI MEDICAL APPOINTS RHONDA ROBB AS PRESIDENT AND CHIEF EXECUTIVE OFFICER

Moomoo AI

Nov 11, 2023 06:38

The increased insider selling of Inari Medical stock over buying in the last three months along with the year-long trend of insider transactions indicate caution despite high insider ownership. Company risk factors should also be considered alongside insider behavior.

Insider Spends US$3.0m Buying More Shares In Inari Medical

Moomoo AI

Nov 6, 2023 06:55

The future looks bleak with predicted negative returns; current investors should consider de-risking. For potential investors, a negative growth outlook raises the risk of holding the Inari Medical stock. Careful examination of further insights and warning signs is advised before investing.

At US$48.30, Is Inari Medical, Inc. (NASDAQ:NARI) Worth Looking At Closely?